Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 41051-41100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06141811
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial
N/ARecruiting
104 participants
Started: Apr 25, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor4 locations
NCT05528926
RESist Against Irritability Superiority Trial
NARecruiting
270 participants
Started: Apr 25, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT05491031
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
NARecruiting
250 participants
Started: Apr 25, 2023 · Completed: May 1, 2028
2 conditions1 sponsor1 location
NCT05963490
Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
PHASE2Recruiting
108 participants
Started: Apr 25, 2023 · Completed: Apr 25, 2026
1 condition1 sponsor1 location
NCT05019703
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
PHASE2Recruiting
40 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2027
5 conditions1 sponsor1 location
NCT05806060
Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer
PHASE3Recruiting
192 participants
Started: Apr 25, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05779215
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
N/ARecruiting
50,000 participants
Started: Apr 25, 2023 · Completed: Dec 30, 2032
1 condition1 sponsor1 location
NCT05885594
Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study
EARLY_PHASE1Recruiting
90 participants
Started: Apr 25, 2023 · Completed: Mar 15, 2027
1 condition1 sponsor1 location
NCT05763862
Genotype Guided Antiplatelet Therapy in Ischemic Stroke
NARecruiting
350 participants
Started: Apr 24, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05820555
The Goodnight Screen Media Study
NARecruiting
180 participants
Started: Apr 24, 2023 · Completed: Aug 31, 2026
2 conditions4 sponsors1 location
NCT05861505
COLLISION RELAPSE Trial
PHASE3Recruiting
360 participants
Started: Apr 24, 2023 · Completed: May 1, 2028
6 conditions1 sponsor1 location
NCT05700461
Drug Screening Using Novel IMD in Renal Cell Carcinoma
PHASE1Recruiting
5 participants
Started: Apr 24, 2023 · Completed: Mar 31, 2026
3 conditions1 sponsor1 location
NCT05632978
An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
N/ARecruiting
2,000 participants
Started: Apr 24, 2023 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT06309680
Accuracy of Metagenomic Blood Sampling to Identify Pathogen in Infective Endocarditis Patients
N/ARecruiting
200 participants
Started: Apr 24, 2023 · Completed: Oct 1, 2025
1 condition3 sponsors1 location
NCT05269160
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)
PHASE1/PHASE2Recruiting
37 participants
Started: Apr 24, 2023 · Completed: Jan 31, 2028
2 conditions1 sponsor3 locations
NCT05710211
Clonal Architecture of ASXL1-mutated Myelofibrosis
NARecruiting
50 participants
Started: Apr 24, 2023 · Completed: Apr 30, 2031
1 condition1 sponsor13 locations
NCT05789602
A Study of BPI-460372 in Advanced Solid Tumor Patients
PHASE1Recruiting
82 participants
Started: Apr 24, 2023 · Completed: Apr 17, 2026
1 condition1 sponsor11 locations
NCT05809011
Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF)
PHASE2/PHASE3Recruiting
120 participants
Started: Apr 24, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05961982
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study
NARecruiting
84 participants
Started: Apr 24, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06137885
REgiStry-based Cardiovascular qUality improvEment Research
N/ARecruiting
2,000 participants
Started: Apr 24, 2023 · Completed: May 31, 2026
4 conditions2 sponsors1 location
NCT05473273
Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.
N/ARecruiting
40 participants
Started: Apr 24, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05956236
Hip Prospective Study
N/ARecruiting
5,000 participants
Started: Apr 24, 2023 · Completed: Apr 30, 2046
1 condition1 sponsor1 location
NCT05599347
Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
PHASE2Recruiting
180 participants
Started: Apr 24, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor9 locations
NCT05852600
Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents
NARecruiting
350 participants
Started: Apr 24, 2023 · Completed: Aug 2, 2026
2 conditions4 sponsors1 location
NCT05507905
Effects of Dance and Music Appreciation on Brain Health and Fitness in People at Risk for Alzheimer's Disease
NARecruiting
160 participants
Started: Apr 24, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06659809
2-Brain Regulation to Achieve Improved Neuroprotection During Early Development
NARecruiting
159 participants
Started: Apr 24, 2023 · Completed: Apr 24, 2026
1 condition3 sponsors2 locations
NCT05674981
To Evaluate the Beneficial Effect of Probiotics on DKD Patients and the Role of Gut Microbiota Modulation
NARecruiting
50 participants
Started: Apr 24, 2023 · Completed: Feb 28, 2025
1 condition2 sponsors1 location
NCT05604404
Effects of Head-of-Bed on Intracranial Pressure
NARecruiting
15 participants
Started: Apr 24, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05652101
Hyperekplexia : Adaptative Skills and Neurodevelopmental Trajectory
N/ARecruiting
40 participants
Started: Apr 24, 2023 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT05627440
A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure
NARecruiting
120 participants
Started: Apr 24, 2023 · Completed: Dec 31, 2027
2 conditions2 sponsors2 locations
NCT06324084
PATHophysiology of OSteoporosis: Role of Hidden Cortisol Excess and Its Predictors in Bone Fragility
N/ARecruiting
1,500 participants
Started: Apr 24, 2023 · Completed: Apr 24, 2025
3 conditions1 sponsor5 locations
NCT05701085
Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities
NARecruiting
240 participants
Started: Apr 24, 2023 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location
NCT05191680
TherApeutics in Early ProState Cancer (TAPS02)
PHASE2Recruiting
90 participants
Started: Apr 24, 2023 · Completed: Oct 31, 2029
1 condition3 sponsors6 locations
NCT05804591
Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).
PHASE4Recruiting
90 participants
Started: Apr 24, 2023 · Completed: Aug 1, 2025
4 conditions1 sponsor1 location
NCT05775159
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
PHASE2Recruiting
260 participants
Started: Apr 24, 2023 · Completed: Dec 14, 2026
2 conditions1 sponsor61 locations
NCT05853952
Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae
NARecruiting
30 participants
Started: Apr 24, 2023 · Completed: Apr 23, 2026
1 condition1 sponsor1 location
NCT06188351
Three Dimensional Navigation IntraCardiac Guidance Kit for Atrial Septal Puncture
NARecruiting
136 participants
Started: Apr 24, 2023 · Completed: Sep 1, 2024
1 condition2 sponsors1 location
NCT05675605
A Study of TY-1091 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
248 participants
Started: Apr 24, 2023 · Completed: Dec 1, 2025
4 conditions1 sponsor1 location
NCT06146530
Cerina-A Pilot Randomized Controlled Trial
NARecruiting
90 participants
Started: Apr 24, 2023 · Completed: Aug 31, 2024
3 conditions3 sponsors1 location
NCT05744687
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
PHASE2/PHASE3Recruiting
374 participants
Started: Apr 24, 2023 · Completed: May 31, 2026
1 condition1 sponsor9 locations
NCT05658289
Latarjet vs Anatomic Glenoid Reconstruction
NARecruiting
68 participants
Started: Apr 24, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05634252
Undergraduate Skin Cancer Prevention Trial
PHASE3Recruiting
528 participants
Started: Apr 24, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06103123
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
N/ARecruiting
500 participants
Started: Apr 23, 2023 · Completed: Apr 23, 2025
4 conditions1 sponsor1 location
NCT05548283
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
PHASE4Recruiting
730 participants
Started: Apr 23, 2023 · Completed: Nov 15, 2026
2 conditions4 sponsors60 locations
NCT06242067
Second-line Treatment of Metastatic Colorectal Cancer
PHASE2Recruiting
50 participants
Started: Apr 23, 2023 · Completed: Dec 31, 2026
1 condition8 sponsors1 location
NCT05198076
6 Month Follow up Study on the Changes of Postural Stability in Parkinsonian Patients in Response to High Frequency TMS.
NARecruiting
40 participants
Started: Apr 23, 2023 · Completed: Apr 28, 2024
1 condition1 sponsor1 location
NCT05742516
Does Galactooligosaccharide Enhance Nutrient Availability
NARecruiting
30 participants
Started: Apr 23, 2023 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05146297
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
NARecruiting
644 participants
Started: Apr 23, 2023 · Completed: Mar 31, 2026
3 conditions1 sponsor3 locations
NCT05775432
Prognosis of Heart Transplanted Patients With Heart Failure
N/ARecruiting
1,000 participants
Started: Apr 23, 2023 · Completed: Dec 31, 2042
1 condition1 sponsor1 location
NCT05650580
TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors
PHASE1Recruiting
26 participants
Started: Apr 23, 2023 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location